Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1970 2
1975 1
1979 1
1980 1
1982 1
1983 1
1984 2
1985 2
1986 3
1987 1
1988 5
1989 5
1990 2
1991 8
1992 6
1993 6
1994 4
1995 5
1996 7
1997 12
1998 10
1999 11
2000 12
2001 13
2002 16
2003 26
2004 32
2005 48
2006 51
2007 55
2008 67
2009 76
2010 115
2011 111
2012 144
2013 170
2014 201
2015 242
2016 274
2017 289
2018 379
2019 418
2020 566
2021 654
2022 760
2023 752
2024 343

Text availability

Article attribute

Article type

Publication date

Search Results

5,272 results

Results by year

Filters applied: . Clear all
Page 1
Corrigendum to "Achyranthes polysaccharide based dual-responsive nano-delivery system for treatment of rheumatoid arthritis" [Int. J. Biol. Macromol. Volume: 234, 15 April 2023, 123677].
Guo C, Diao N, Zhang D, Cao M, Wang W, Geng H, Kong M, Chen D. Guo C, et al. Among authors: cao m. Int J Biol Macromol. 2024 May 18;270(Pt 1):132204. doi: 10.1016/j.ijbiomac.2024.132204. Online ahead of print. Int J Biol Macromol. 2024. PMID: 38763099 No abstract available.
Corrigendum to "N-acetylneuraminic acid and chondroitin sulfate modified nanomicelles with ROS-sensitive H2S donor via targeting E-selectin receptor and CD44 receptor for the efficient therapy of atherosclerosis" [Int. J. Biol. Macromol. Vol. 211 Page 259-270].
Chen Q, Guo C, Zhou X, Su Y, Guo H, Cao M, Li J, Zhang Y, Zhao W, Gao X, Mi S, Chen D. Chen Q, et al. Among authors: cao m. Int J Biol Macromol. 2024 May 17;270(Pt 1):132202. doi: 10.1016/j.ijbiomac.2024.132202. Online ahead of print. Int J Biol Macromol. 2024. PMID: 38761610 No abstract available.
Efficacy and safety of low-dose cyclophosphamide combined with lenvatinib, pembrolizumab and TACE for unresectable hepatocellular carcinoma: A single-center, prospective, single-arm clinical trial.
Ren Y, Li Y, Cao M, Tang Y, Yuan F, Yang G, He Z, Shi Z, Su X, Yao Z, Deng M. Ren Y, et al. Among authors: cao m. Chin J Cancer Res. 2024 Apr 30;36(2):114-123. doi: 10.21147/j.issn.1000-9604.2024.02.02. Chin J Cancer Res. 2024. PMID: 38751440 Free PMC article.
5,272 results